Skip to main content
. 2013 Apr 8;6:137. doi: 10.1186/1756-0500-6-137

Table 5.

Comparison of viral marker negative HCC with HCV-HCC, HBV-HCC, combination-HCC

 
Percentages
Unadjusted OR(95% CI)
Adjusted OR(95% CI)
Variable HCV HBV Combination NBN HBV Combination NBNC HBV NBNC Combination
Gender
 
 
 
 
 
 
 
 
 
 
  Female
35.6
17.6
17.9
25.3
1
 
 
1
 
 
  Male
64.4
82.4
82.1
74.7
2.5 (1.5-4.3)
2.5 (1.2-5.1)
1.6 (0.9-2.6)
2.3 (1.3-3.8)
1.5 (0.8-2.5)
2.6 (1.2-5.3)
Diagnosis of HCC
 
 
 
 
 
 
 
 
 
 
  On screening
11.9
2.5
1.9
1.0
1
 
 
1
 
 
  incidental
8.1
9.2
5.4
13.1
5.3 (1.3-20.9)
0.88 (0.19-3.96)
19.06 (2.3-153.5)
3.4 (0.8-13.9)
10.1 (1.2-84.7)
0.8 (0.17-3.8)
  symptomatic
80.1
88.2
85.7
85.9
5.1 (1.5-17.0)
1.4 (0.53-3.76)
12.5 (1.7-92.7)
4.1 (1.2-13.9)
8.1 (1.1-60.3)
1.4 (0.5-3.9)
BMI (Kg/m2)
 
 
 
 
 
 
 
 
 
 
  18-22.9
26.7
35.3
26.8
25.3
1
 
 
1
 
 
  <18
3.8
11.8
3.6
10.1
2.3 (1.03-2.37)
0.94 (0.19-4.56)
2.8 (1.12-7.11)
2.8 (1.2-6.6)
3.1 (1.1-8.3)
1.1 (0.2-5.0)
  23-24.9
22.9
21.0
26.8
27.3
0.69 (0.39-1.23)
1.16 (0.53-2.52)
1.25 (0.53-2.52)
0.7 (0.3-1.3)
1.3 (0.6-2.4)
1.1 (0.5-2.4)
  ≥ 25
46.6
31.9
42.9
37.4
0.51 (0.31-0.85)
0.91 (0.45-1.82)
0.84 (0.48-1.48)
0.6 (0.3-1.1)
0.9 (0.5-1.7)
1.0 (0.5-2.0)
Maximum diameter (cm)
 
 
 
 
 
 
 
 
 
 
  <5
62.5
49.6
62.5
33.3
1
 
 
1
 
 
  5-10
29.1
39.5
32.1
40.5
1.7 (1.09-2.6)
1.1 (0.59-2.0)
2.6 (1.5-4.3)
1.5 (0.9-2.5)
2.3 (1.3-4.0)
0.9 (0.5-1.7)
  >10
8.4
10.9
5.4
26.3
1.64 (0.8-3.3)
0.64 (0.18-2.2)
5.8 (3.1-11.1)
1.0 (0.5-2.2)
4.0 (2.0-7.9)
0.5 (0.1-1.7)
Duration between diagnosis of CLD and HCC
  >55
22.1
6.7
19.6
10.1
1
 
 
1
 
 
  zero
37.5
52.1
44.6
65.7
4.5 (2.0-10.0)
1.3 (0.62-2.8)
3.8 (1.8-7.8)
3.7 (1.6-8.4)
3.0 (1.4-6.5)
1.1 (0.4-2.4)
  1-55
40.4
41.2
35.7
24.2
3.3 (1.5-7.4)
0.9 (0.4-2.1)
1.3 (0.5-2.8)
2.6 (1.1-6.1)
1.2 (0.5-2.8)
0.7 (0.3-1.7)
Diabetes
 
 
 
 
 
 
 
 
 
 
  No
55.8
72.3
78.6
49.5
1
 
 
1
 
 
  Yes 44.2 27.7 21.4 50.5 0.48 (0.30-0.76) 0.34 (0.17-0.67) 1.2 (0.8-2.0) 0.5 (0.3-0.9) 1.6 (0.1-2.5) 0.3 (0.2-0.6)